Was it a Sufficient Oversizing in the PARTNER 3 Trial?
- PMID: 35057995
- DOI: 10.1016/j.jcin.2021.11.009
Was it a Sufficient Oversizing in the PARTNER 3 Trial?
Comment in
-
Reply: Was it a Sufficient Oversizing in the PARTNER 3 Trial?JACC Cardiovasc Interv. 2022 Jan 24;15(2):228-229. doi: 10.1016/j.jcin.2021.12.003. JACC Cardiovasc Interv. 2022. PMID: 35057996 No abstract available.
Comment on
-
Impact of Annular Oversizing on Paravalvular Regurgitation and Valve Hemodynamics: New Insights From PARTNER 3.JACC Cardiovasc Interv. 2021 Oct 11;14(19):2158-2169. doi: 10.1016/j.jcin.2021.07.018. JACC Cardiovasc Interv. 2021. PMID: 34620395
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources